Skip to Content
Merck
All Photos(1)

Documents

G004432

HPLC Analysis of Statins in Rat Plasma on Ascentis® Express C18 after SPE using Supel-Select HLB

application for SPE, application for LC-MS

Sign Into View Organizational & Contract Pricing


About This Item

technique(s)

LC/MS: suitable
solid phase extraction (SPE): suitable

test parameters

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: rat plasma spiked with provastin and atorvastin at 5 and 100 ng/mL
SPE tube/cartridge: Supel-Select HLB SPE, 30 mg/1 mL (54181-U)
condition: 0.5 mL methanol:acetonitrile (1:1, v/v); 0.5 mL DI water
sample addition: 0.5 mL
washing: 0.5 mL 5% methanol
elution: 0.5 mL methanol:acetonitrile (1:1, v/v)
column: Ascentis Express C18, 5 cm x 2.1 mm, 2.7 μm particles (53822-U)
eluate post-treatment: evaporate to dryness with nitrogen at 37 °C, reconstitute in 0.5 mL DI water
mobile phase: 0.1% acetic acid diluted in 60% methanol
flow rate: 0.2 mL/min
column temp.: 35 °C
detector: ABI 3200 QT; ESI(+), MRM (423.3/321.3, 423.3/101.0, 557.3/397.2 and 557.3/453.4)
injection: 5 μL

suitability

application for LC-MS
application for SPE

application(s)

clinical

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
Supel is a trademark of Sigma-Aldrich Co. LLC

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service